Aladdin Healthcare Technologies SE
ALDNF · OTC
6/30/2021 | 12/31/2020 | 6/30/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | – | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | – | $11 | $11 | $1 |
| Gross Profit | – | -$11 | -$11 | -$1 |
| % Margin | – | – | – | – |
| R&D Expenses | – | $115 | $115 | $274 |
| G&A Expenses | – | $164 | $164 | $428 |
| SG&A Expenses | – | $170 | $170 | $429 |
| Sales & Mktg Exp. | – | $6 | $6 | $1 |
| Other Operating Expenses | – | $6 | $6 | $0 |
| Operating Expenses | – | $521 | $521 | $896 |
| Operating Income | – | -$664 | -$664 | -$857 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | – | -$198 | -$198 | -$745 |
| Pre-Tax Income | – | -$722 | -$722 | -$1,660 |
| Tax Expense | – | -$104 | -$104 | -$165 |
| Net Income | – | -$616 | -$616 | -$1,495 |
| % Margin | – | – | – | – |
| EPS | – | -0.055 | -0.055 | -0.095 |
| % Growth | – | 0% | 42.1% | – |
| EPS Diluted | – | -0.055 | -0.055 | -0.095 |
| Weighted Avg Shares Out | – | 11,455 | 11,455 | 15,660 |
| Weighted Avg Shares Out Dil | – | 11,455 | 11,455 | 15,660 |
| Supplemental Information | – | – | – | – |
| Interest Income | – | $0 | $0 | $48 |
| Interest Expense | – | $58 | $58 | $36 |
| Depreciation & Amortization | – | $11 | $11 | $767 |
| EBITDA | – | -$653 | -$653 | -$90 |
| % Margin | – | – | – | – |